epsilon-V1-2, PKCe Inhibitor, Cys-conjugated – 1 mg

Overview

The epsilon-V1-2, PKCe Inhibitor, Cys-conjugated is a targeted peptide designed for research into εPKC functions and signaling pathways. This specific inhibitor plays a crucial role in studying the translocation of εPKC and its interaction with MARCKS phosphorylation. By interfering with the εPKC and εRACK anchoring protein interaction, this peptide provides an essential tool for those investigating complex cellular mechanisms.

Key Features

• Specifically inhibits εPKC activity
• Interferes with εPKC’s interaction with εRACK
• Cysteine residue included for S-S bond formation with a carrier protein
• Useful in studying signaling pathways and phosphorylation processes
• High purity and reliability for laboratory applications

Specifications

FAQ

How does the epsilon-V1-2 inhibitor work?

This peptide specifically targets εPKC, reducing its interaction with εRACK, thereby influencing downstream signaling processes.

Can I use this peptide for in vivo studies?

The epsilon-V1-2 peptide is primarily designed for in vitro research applications. Always consult product data sheet recommendations for in vivo study considerations.

What are the storage conditions for this peptide?

Store the epsilon-V1-2 peptide at -20°C to maintain its stability and efficacy. Avoid multiple freeze-thaw cycles.

For a complete understanding of PKCe pathways, consider exploring related peptides such as Autocamtide-2 and CREBtide. For additional peptide options, check out our extensive range of peptides tailored for your specific research needs.

Related Products

• PKG Substrate [RKRSRAE], Glasstide